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1.   INTRODUCTION 
Neuromuscular blocking agents are commonly used to facilitate 
tracheal intubation. 
A perfect setting for tracheal intubation include a rapid onset, 
profound paralysis of all muscles and short duration of action so that the 
patients own respiratory function can be restored should intubation prove 
to be impossible. 
These requirements are best met by succinylcholine, an ultrashort 
acting depolarizing muscle relaxant. However its many unwanted side 
effects have necessitated a search for an alternative drug or technique to 
facilitate tracheal intubation. 
The introduction of each new muscle relaxant has advanced 
anaesthetic practice by trying to meet some perceived deficiency in the 
existing therapeutic armamentarium. 
Rocuronium bromide is a steroid, non-depolarizing neuromuscular 
blocking agent with a rapid onset and an intermediate duration of action. It 
may be a suitable alternative to succinylcholine.  
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2.  AIM OF STUDY 
 To study and compare the efficacy of rocuronium bromide in two 
dosage schedules – 0.6mg / kg (2 x ED95) and 0.9mg / kg  
(3 x ED95) IV, with succinylcholine chloride 1.5mg / kg IV in patients with 
respect to: 
1. Intubating conditions at one minute 
2. Onset of action 
3. Adverse effects 
 
 
 
 
 
3.  PHARMACOLOGY 
(i) SUCCINYLCHOLINE CHLORIDE 
History 
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 Prepared in 1906 by Reid Hunt and Taveau of Boston. Its 
neuromuscular blocking effects are described in 1948 by Bovet and his 
colleagues and J.C. Castillo and Edwin de Beer. It was introduced in to 
anaesthetic practice by Thesleff (1951) and Foldes et al (1952). 
Chemistry 
 It is the dicholine ester of succinic acid (equivalent to two molecules 
of acetylcholine joined back to back) 
Molecular Structure 
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Routes of administration : Intravenous, intra-muscular 
Dose : ED95   Adult   290 µg/kg 
   Children  352 µg/kg 
   Infants  608 µg/kg 
   Neonates  517 µg/kg 
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 For tracheal intubation 1.0 to 2.0 mg/kg 
Onset of action  : 30 to 60 seconds 
Duration of action : 3 to 6 minutes 
Pharmacokinetics : 
Metabolism   : 
 98 to 99% of Succinylcholine is hydrolyzed in the plasma by 
pseudocholinesterase. The metabolites are succinylmonocholine, succinic 
acid and choline. The neuromuscular blockade produced by 
succinylcholine is terminated by its diffusion away from the neuromuscular 
junction back into the circulation. Pseudocholinesterase influences the 
onset and duration of succinylcholine by controlling the rate at which the 
drug is hydrolyzed before and after it reaches the neuromuscular junction. 
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Excretion 
 Less than 2% of an administered dose is excreted unchanged in the 
urine. 
 In vivo hydrolysis rate  : 3 – 7 mg/ml/minute 
 Half-life   : 2.7 – 4.6 minutes 
Pharmacodynamics 
Neuromuscular Junction 
 Succinylcholine initially mimics the action of acetylcholine at the 
nicotinic cholinergic receptors (binds to the two alpha subunits) in the 
post-junctional membrane causing muscle contraction followed by 
relaxation. Depolarizing blockade (phase I block) is characterized by 
a. Muscle fasciculations preceding the onset of block, 
b. Depression of twitch height, 
c. Absence of fade with train-of-four (TOF) or tetanic 
stimulation, 
d. TOF ratio > 0.7, 
e. Absence of post-tetanic facilitation and  
f. Potentiation of block by anticholinesterases, 
Cardiovascular system 
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 Succinylcholine stimulates all cholinergic autonomic receptors. 
Nicotinic receptors on both sympathetic and parasympathetic ganglia and 
muscarinic receptors in the sinus node of the heart are stimulated. In low 
doses, both negative inotropic and chronotropic responses may occur. 
These can be attenuated by prior administration of atropine. This 
generalized autonomic stimulation may result in cardiac arrhythmias. 
Side Effects 
1. Cardiac arrhythmias:  Sinus bradycardia, nodal (junctional) rhythms, 
ventricular arrhythmias. 
2. Fasciculations – uncoordinated muscle twitching. Infrequent in 
infants and children. 
3. Post-anaesthetic myalgias. 
4. Hyperkalemia:  Serum potassium transiently increases by 0.2 to 0.5 
mmol/L in normal individuals. This effect is exaggerated in burns 
patients (24 hours to 2 years), post-trauma (7 days to 60 days) and in 
patients with neuromuscular disease or nerve damage (within 6 
months). 
5. Increased intra-ocular pressure. 
 11
6. Increased intra-cranial pressure. 
7. Increased intragastric pressure. 
8. Salivation and gastric secretions are increased. 
9. Allergic reactions. 
10. Association with masticatory muscle stiffness, masseter spasm and 
malignant hyperthermia. 
11. Prolonged apnoea – SCOLINE APNOEA with abnormal 
pseudocholinesterase which is genetically determined in certain 
community, or an acquired deficiency of pseudocholinesterase as  
pregnancy, malnutrition and liver disease.  
12. Phase II block – Prolonged administration or large doses of 
succinylcholine produces a blockade which has non-depolarizing 
characteristics. 
Contra-indications to the use of succinylcholine  
 Succinylcholine is strictly contraindicated in certain disease states: 
1. Patients who have a family history or known susceptibility to 
malignant hyperthermia. In these patients, succinylcholine 
may cause rhabdomyolysis, hyperkalemia and cardiac asystole. 
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2. Muscular dystrophies 
3. Myotonia. 
4. Post-burns (24 hrs to 2 years). 
5. Neurologic disease (eg. Paraplegia, stroke) (within 6 months). 
6. Post-crush injuries (7 to 60 days) 
7. History of prolonged apnoea in previous surgeries. 
Presentation 
 As a clear aqueous solution containing 50mg/ml of succinylcholine 
chloride.It is also available as powdered form. 
Cost 
 Rs.31/500 mg 
(ii) ROCURONIUM BROMIDE 
 Originally synthesized and studied in the Organon Teknika 
Laboratories as ORG 9426. Introduced into clinical practice in 1994. 
Chemistry 
 Rocuronium is a steroidal muscle relaxant of intermediate duration. 
It is the 2-morpholino, 3-hydroxy, 16-N-allyl-pyrrolidino derivative of 
vecuronium. 
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 1-[(2β, 3α, 5α, 16β, 17β)-17-(acetyloxy) - 3 - hydroxy - 2 - (4-
morpholinyl)-androstan-1-yl]-1-(2-propenyl) pyrrolidium bromide. 
Molecular Structure 
 
 
 
 
 
Table I  
PHARMACOKINETICS OF ROCURONIUM BROMIDE 
Age group 
Volume of 
distribution at steady 
state (VDSS) (ml/kg)
Clearance 
ml/kg/min 
Elimination 
half-life 
Normal Adult 207 2.89 ± 0.25 70.9 ± 4.7 
Elderly 399 ± 122 3.67 ± 1 08 ± 69.1 
Children 224 2.67 46 to 55 
 
Pharmacodynamics  
Neuromuscular Junction 
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 It produces non-depolarizing muscle paralysis by competitive 
antagonism of acetylcholine at nicotinic receptors in the post-synaptic 
membrane of the neuromuscular junction. It also has some pre-junctional 
action. Non-depolarizing blockade is characterized by 
a. Depression of twitch height, 
b. Fade with train-of-four or tetanic stimulation 
c. TOF ratio < 0.7, 
d. Post-tetanic facilitation, and  
e. Antagonism of block by anticholinesterases. 
It is 7 to 8 times less potent than Vecuronium but has a faster onset. 
Paralysis occurs first in the well-perfused fast muscles and last in the 
diaphragm. Onset of block is faster but less intense at the adductor 
muscles of the larynx than at the adductor pollicis muscle, while the 
diaphragm is affected later but recovers earlier than the adductor pollicis 
muscle. 
The action of Rocuronium can be increased by the presence of 
hypokalemia, hypermagnesemia, hypocalcemia, hypoproteinemia, 
dehydration, acidosis, hypercapnia and cachexia. Under hypothermic 
conditions the neuromuscular blocking effect of Rocuronium is increased 
and the duration prolonged. 
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Cardiovascular system 
 The autonomic safety ratio for vagal block (3.0 to 5.0) is about 10 
times less than that of Vecuronium. Reports of slight to moderate 
increases in heart rate may be due either to Rocuronium producing pain on 
injection or to its weak vagolytic effect. The heart rate increase may be 
controlled by the prior administration of fentanyl. Rocuronium in doses 
upto 0.6 mg/kg has cardiovascular effects that are negligible. At higher 
does (0.9 to 1.2 mg/kg) increases in heart rate of 10 to 25% have been 
observed. 
Histamine releasing property 
 Rocuronium is not associated with clinical signs of histamine release 
in doses upto 5 x ED95. 
Anaphylaxis / Anaphylactoid reactions 
 In terms of allergy, Rocuronium appears to have a good safety 
profile. 
Central nervous system 
 No effect as it does not cross the blood-brain barrier. Intracranial 
pressure is not increased. 
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Intraocular pressure 
 Minimal changes in intraocular pressure. Appears to be safe for use 
in rapid-sequence induction of anaesthesia for perforating eye injuries. 
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Placental transfer 
 Rocuronium does not cross the placenta in significant amounts. 
Pseudocholinesterase inhibition 
 This may result in the prolongation of action of drugs dependent on 
cholinesterases for their metabolism like succinylcholine and mivacurium. 
The antipseudocholinesterase activity of Rocuronium is less than that of 
Vecuronium. 
Presentation 
 As a clear colourless solution containing 10mg/ml of Rocuronium 
bromide. The drug is available in 5 and 10 ml ampoules/vials. 
Cost 
 Rs.330/50 mg. 
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4. MONITORING NEUROMUSCULAR 
TRANSMISSION 
 Neuromuscular transmission monitoring is the continuous 
measurement of the effect of muscle relaxants on the  neuromuscular 
junction in the muscles. 
Importance 
 The monitoring of neuromuscular function during and after an 
anaesthetic provides valuable clinical information. 
1. At induction, it indicates when good intubating conditions are 
achieved.  
2. During the course of surgery, it indicates the degree of 
muscle relaxation. 
3.  At the end of anaesthesia, it indicates adequacy and 
appropriate time of reversal. 
4.  It permits appropriate titration of the dose of muscle 
relaxant to the degree necessary for performing surgery. 
 It is useful in the intensive care unit to avoid overdosage, residual 
recurarization or tachyphylaxis. 
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Principles of peripheral nerve stimulation 
Neuromuscular function is monitored by evaluating the response of 
a muscle to supramaximal electrical stimulation of a peripheral motor 
nerve. 
1. A supramaximal stimulus is 20 to 25% above that necessary 
for a maximal response. 
2. The character of the waveform produced by the electrical 
impulse should be monophasic and rectangular. 
3. The optimal pulse duration is 0.2 to 0.3 ms. 
After administration of a neuromuscular blocking drug, the response 
of the muscle decreases in parallel with the number of fibres blocked, 
reflecting the degree of neuromuscular blockade. 
Patterns of nerve stimulation 
1. Single-twitch stimulation 
2. Train-of-four (TOF) stimulation 
3. Tetanic stimulation 
4. Post-tetanic count (PTC) 
5. Double burst stimulation (DBS) 
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1. SINGLE-TWITCH STIMULATION (ST) 
  A single supramaximal stimulus lasting 0.2 msec is applied to a 
peripheral nerve at a frequency ranging from 1.0 Hz to 0.1 Hz. 
 
 
 
 
 
 
 
 
A control twitch height is established prior to administration of 
muscle relaxant so that the degree of blockade can be assessed by 
comparing the percentage of twitch height to that of control. 
 The single twitch is useful in assessing onset, degree of blockade and 
the recovery time. 
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2. TRAIN-OF-FOUR STIMULATION (TOF) 
 Introduced by Ali et al, during the early 1970s, four supramaximal 
stimuli are given every 0.5 second (2Hz). 
 
 
 
 
 
 
Each stimulus in the train causes the muscle to contract. Fade in the 
response provides the basis for evaluation. Dividing the amplitude of the 
fourth response by the amplitude of the first response provides the TOF 
ratio ( T4 /T1 ) 
 In the control response (the response obtained before 
administration of muscle relaxant), all four responses are ideally the same : 
the TOF ratio is 1.0. 
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 During a partial non-depolarizing block, the ratio decreases (‘fades’) 
and is inversely proportional to the degree of blockade. During a partial 
depolarizing block, no fade occurs in the TOF response. 
 The advantage of TOF stimulation is that it obviates the need for a 
pre-relaxant baseline twitch height determination. TOF thus serves as its 
own control. 
3.  TETANIC STIMULATION (TS) 
 Tetanic stimulation is the mode in which the nerve is stimulated 50 
times per second (50 Hz) or 100 times per second (100 Hz) for 5 seconds. 
It detects whether the response is sustained or fades during the stimulus. 
 During depolarizing block the peak tension is decreased but 
sustained. With non-depolarizing block and with phase II block peak 
height decreases and fades. 
 Tetanic stimulation is very painful and should be applied only to 
anaesthetized patients 
4. POST-TETANIC COUNT (PTC) 
 It is possible to quantify intense neuromuscular blockade of the 
peripheral muscles by applying tetanic stimulation (50 Hz for 5 sec) and 
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observing the post-tetanic response to single twitch stimulation given at 1 
Hz starting 3 seconds after the end of tetanic stimulation. During very 
intense blockade, there is no response to either titanic or post-tetanic 
stimulation. 
The main application of the PTC method is in evaluating the degree 
of neuromuscular blockade when there is no reaction to single-twitch or 
TOF nerve stimulation. 
5. DOUBLE BURST STIMULATION (DBS) 
 This mode of stimulation is a refinement of the TOF, particularly 
for tactile or visual evaluation of full recovery of muscle strength. 
 DBS consists of two short bursts of 50 Hz tetanic stimulation 
separated by 750 msec. In the DBS3,3 mode, 3 stimuli are given twice. In 
the DBS3,2 mode, 3 and 2 stimuli are given in each burst. 
 When a non-depolarizing muscle relaxant is given, fading takes place 
between these two bursts. Interpretation is based on comparison of the 
two responses produced by this type of stimulation. 
Sites of nerve stimulation and different muscle responses 
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 In principle any motor nerve innervating muscles with a clearly 
visible motor response lends itself to neuromuscular monitoring. The 
following nerves may be used as they are superficial: 
1. the ulnar nerve, 
2. the median nerve, 
3. the posterior tibial nerve, 
4. the common peroneal nerve and  
5. the facial nerve 
In clinical anaesthesia, the ulnar nerve is the most popular site. For 
stimulation of the ulnar nerve, the electrodes are best applied at the volar 
side of the wrist. The distal electrode should be placed about 1 cm 
proximal to the point at which the proximal flexion crease of the wrist 
crosses the radial side of the tendon to the flexor carpi ulnaris muscle. The 
proximal electrode should be placed 2 to 5 cm proximal to the distal 
electrode. With this placement of the electrodes, electrical stimulation 
normally elicits only finger flexion and thumb adduction. 
Recording of evoked responses 
 Three methods are available: 
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1. Mechanomyography: Measurement of evoked mechanical 
responses. 
2. Eletromyography (EMG): Measurement of evoked electrical 
responses. 
3. Acceleromyography : Measurement of acceleration of the 
muscle response. 
5. REVIEW OF LITERATURE 
A rapid predictable onset of neuromuscular blockade is a pre-
requisite for smooth tracheal intubation. Succinylcholine is the standard 
neuromuscular blocking agent for this purpose. However, it has several 
side effects, some of which are inconvenient while others may be harmful. 
 Literature was reviewed to compare intubating conditions, onset of 
action and adverse effects of Rocuronium bromide and Succinylcholine. 
1. Wierda J.M.K.H., et al (1990)24 showed that a dose of 0.5 mg/kg 
of Rocuronium produced 75% blockade in 68 seconds, complete 
blockade in 200 seconds and recovery to 25% of T1 in 34 minutes. 
2. Meistelman C., et al (1994)16 found that onset time, intensity of 
blockade and duration of action were less at the larynx than at the 
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adductor pollicis with 0.5 mg/kg of Rocuronium. The onset times 
were 1.4 ± 0.1  and 2.4 ± 0.2 minutes at the laryngeal muscles and 
adductor pollicis, respectively. Maximum blockade was 77 ± 5% and     
98 ± 1% respectively (p=0.01) and time to 90% T1 recovery was 22 
minutes. 
3. Jean Paul Cantinueau, et al (1994)11 found that the diaphragm is 
more resistant than the adductor pollicis to Rocuronium 0.6 mg/kg. 
The onset time for muscle relaxation after 0.6 mg/kg Rocuronium 
was shorter for the adductor pollicis muscle than for the diaphragm 
(80 ± 20 vs 120 ± 62 sec). Times for 10%, 25%, 75% and 90% 
recovery of twitch height were 34 ± 10, 40 ± 13, 56 ± 20 and 64 ± 
21 minutes, respectively for the adductor pollicis, and significantly 
shorter for the diaphragm, 17 ± 10, 23 ± 9, 33 ± 13 and 35 ± 10 
minutes, respectively. The intubating dose of 0.6 mg/kg is close to 
the ED95 of 0.5 mg/kg for the diaphragm. 
4. Peter M.C. Wright, et al (1994)20 studied the onset and duration of 
Rocuronium and Succinylcholine at the adductor pollicis and 
laryngeal adductor muscles in anaesthetized adults. They found that 
the onset of effect with Succinylcholine was significantly more rapid 
at the laryngeal adductors (34 ± 12 sec) than at the adductor pollicis 
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(56 ± 15 sec). Onset times were similar at the two muscle groups with 
Rocuronium 0.8 and 1.2 mg/kg (96 ± 29 and 74 ± 36 sec with 0.8 
mg/kg and 54 ± 30 and 65 ± 21 sec with 1.2 mg/kg at the laryngeal 
adductors and the adductor pollicis, respectively). Rocuronium 0.4 
mg/kg had a more rapid effect at the laryngeal adductors than the 
adductor pollicis (92 ± 29 sec and 155 ± 40 sec, respectively). 
 They concluded that the laryngeal adductors are more resistant to 
the action of Rocuronium than is the adductor pollicis. Onset of 
effect of Rocuronium in doses greater than 0.8 mg/kg is similar to 
that of Succinylcholine at the adductor pollicis but is significantly 
delayed compared with that of Succinylcholine at the laryngeal 
adductors. 
5. De Mey J.C., et al (1994)7 evaluated onset and intubation 
conditions of Rocuronium bromide 0.6, 0.75 or 0.9 mg/kg in adult 
patients anaesthetized with propofol 2mg/kg and alfentanil 0.5 to 1 
μg/kg. They concluded that a dose of Rocuronium equal to or larger 
than 0.6 mg/kg provides acceptable intubation conditions at 60 
seconds after administration. Onset times were 271 ± 129, 189 ± 
119 and 135 ±  79 seconds following Rocuronium 0.6, 0.75 and 0.9 
mg/kg, respectively. Time taken for recovery of T1 to 25% of 
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control was 27.3 ±  8.2, 43.6 ± 12.0 and 53.0 ± 15.2 minutes in the 3 
groups respectively. 
6. Mirakhur R.K., et al (1994)17 compared onset and intubating 
conditions of Rocuronium bromide 0.6 mg/kg and Succinylcholine 
1 mg/kg in adult patients anaesthetized with Thiopentone, Nitrous 
oxide in Oxygen and small doses of Fentanyl. Intubating conditions 
after Rocuronium 0.6 mg/kg were found to be clinically acceptable 
(good or excellent) in 95% of patients at 60 seconds and in all 
patients at 90 seconds and in all patients at both times after 
succinylcholine. There were no significant difference in acceptable 
intubating conditions between succinylcholine and Rocuronium. 
 The average time for the onset of block following Rocuronium at 
this dose was 89 seconds and duration of clinical relaxation 30 
minutes. For succinylcholine, the corresponding values were 60.4 
seconds and 13 minutes, respectively. The degree of neuromuscular 
block with Rocuronium was 89% at 60 seconds and 98% at 90 
seconds. 
7. Previs TH, Zahn P., et al (1994) Studied the ED95 dose of 
Rocuronium bromide and the tracheal intubating conditions and 
time course of actions. They concluded that ED95 dose of 
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Rocuronium bromide was 0.3 mg/kg and duration of action was 20 
minutes. 
8. Wierda J.M.K.H., et al (1995)25 compared the time course of 
action and intubating conditions following vecuronium, 
Rocuronium and Mivacurium in adults anaesthetized with 
Thiopentone (4 to 6 mg/kg) and Fentanyl (1 to 3 μg/kg). Intubating 
conditions after 2 x ED90 dose of Rocuronium at 90 seconds were 
significantly better than those after Vecuronium and Mivacurium. 
The average onset times of Rocuronium (172 sec) and Vecuronium 
(192 sec) were significantly shorter than that of Atracurium (229 
sec). The clinical duration was significantly shorter after Mivacurium 
(13 min) than with Vecuronium (33 min) and Rocuronium (28 min). 
 They concluded that Rocuronium might be of advantage whenever 
the interval between administration of muscle relaxant and tracheal 
intubation must be short. 
9. Scheiber G., et al (1996)21 Compared 0.6 mg/kg Rocuronium, 0.1 
mg/kg Vecuronium and 0.5mg/kg Atracurium in children during 
Etomidate-Fentanyl-Nitrous oxide anaesthesia and found better 
intubating conditions at 60 seconds after Rocuronium than 120 
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seconds after Vecuronium or at 80 seconds after Atracurium 
administration. 
10. K.Barclay., et al (1997)3 assessed whether low doses of 
Rocuronium improved conditions for tracheal intubation during 
induction of anaesthesia with Propofol 2.5mg/kg and Alfentanil 
10ug/kg. They have studied three groups. One group received 
saline, second group Rocuronium 0.1 mg/kg and the third group 
received 0.3 mg/kg Rocuronium and they assessed in intubating 
conditions as judged by jaw opening and laryngoscopy, position of 
the vocal cords and degree of straining after tracheal intubation. 
They concluded that injection of Rocuronium 0.3 mg/kg with 
Propofol and Alfentanil provided a high proportion of optimal 
intubating conditions. 
11. Fuchs- Buder T., et al (1997)8 showed that in children, 
Rocuronium 0.6mg/kg and 0.9mg/kg with Thiopentone 5mg/kg 
and Alfentanil 10μg/kg offered good to excellent intubating 
conditions for elective rapid sequence induction aat 60 seconds. 
Onset times were 193 ± 43 and 118 ± 23 seconds respectively. 
12.  Weiss JH., et al (1997)23 Studied the intubating conditions in adult 
patients for elective surgery with Rocuronium 0.7mg/kg, 
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Rocuronium 0.9 mg/kg and Succinylcholine 1.5 mg/kg, 
anaesthetized with Fentanyl 2μg/kg and Thiopentone 4-5mg/kg. 
Rocuronium 0.7mg/kg displayed a significant lower score <60% 
and rated as poor. Rocuronium 0.9 mg/kg provides similar 
intubating conditions to Succinylcholine 1.5mg/kg at 60 seconds 
13. Smith I, Saad Rs., et al (1998)22 Compared the onset of action and 
the intubating conditions after Rocuronium 0.6 mg/kg and 
Rocuronium 0.1mg/kg, when the timing of tracheal intubation was 
determined by clinical judgment alone like ease of ventilation, jaw 
and upper airway tone. They concluded that time to laryngoscopy 
and completion of intubation was markedly shorter in the 
Rocuronium group. Rocuronium group also had significantly better 
intubating conditions. 
14.  McCourt K.C., et al (1998)15 compared tracheal intubating 
conditions at one minute during rapid-sequence induction of 
anaesthesia using Rocuronium 0.6mg/kg, Rocuronium 1.0 mg/kg or 
Succinylcholine  1 mg/kg in adult patients, anaesthetized with 
Fentanyl and Thiopentone. Their results showed that intubating 
conditions were significantly superior with 1.0 mg/kg than 0.6 
mg/kg of Rocuronium. Final comparison between 1.0 mg/kg of 
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Rocuronium and 1 mg/kg of Succinylcholine showed no significant 
difference in the incidence of acceptable intubations (96 and 97% 
respectively). The incidence of excellent grade of intubations was 
however, significantly higher with Succinylcholine (80% vs 60%, 
p=0.02). 
 They concluded that Rocuronium 1 mg/kg can be used as an 
alternative to Succinylcholine 1mg/kg as part of rapid-sequence 
induction provided there is no anticipated difficulty in intubation. 
The clinical duration of this dose of Rocuronium was 50 to 60 
minutes. 
15. Kirkegaard-Nielson, H. et al., (1999)12 studied rapid tracheal 
intubation with Rocuronium using a probability based approach. 80 
adult patients anaesthetized with Fentanyl 2 µg/kg and Propofol 2 
mg/kg randomly received Rocuronium 0.0, 0.4, 0.8 or 1.2 mg/kg 
(n=20/dose). Laryngoscopy was initiated at 40 seconds aiming for 
intubation at 60 seconds. Doses giving 90 and 95% (D90 and D95) 
probability of successful intubation were calculated and found to be 
0.83 (0.59 – 1.03) and 1.04 (0.76 – 1.36) mg/kg respectively. 
Estimated times until first tactile train-of-four response after D90 
and D95 doses were 32 and 46 minutes respectively. 
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 They concluded that after induction with Fentanyl and Propofol, 
Rocuronium 1.04 mg/kg gives 95% probability of successful 
intubation at 60 seconds. 
16. Hans P., et al (1999)9 found that Ketamine 2.5 mg/kg provides 
better intubating conditions (excellent and good) than Thiopentone 
5 mg/kg, one minute after Rocuronium 0.6 mg/kg in adult patients, 
100% and 50% respectively. The degree of neuromuscular blockade 
(% decrease of T1) at the time of intubation was similar, 51.8 ± 25% 
(Ketamine group) and 54.3 ± 23% (Thiopentone group). 
17. Andrews JI., et al (1999)1 Compared Rocuronium and 
Succinylcholine for rapid sequence induction of anaesthesia along 
with Propofol and anaesthesia was induced using Propofol 
2.5mg/kg followed immediately by either Rocuronium 0.6 mg/kg or 
1 mg/kg or Succinylcholine 1mg/kg. Intubating conditions were 
assessed at one minute and intubation was performed. They 
concluded Rocuronium 1mg/kg given along with Propofol in a 
rapid sequence induction of anaesthesia is clinically equivalent to 
Succinylcholine 1mg/kg. 
18. A.P. Dobson., et al (1999)2 Compared intubating conditions with 
Thiopentone and Propofol for rapid sequence induction of 
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anaesthesia using 0.6 mg/kg of Rocuronium at 30, 40, 50, 60 and 70 
seconds and they concluded that satisfactory intubating conditions 
are achieved approximately 60 seconds after induction of 
anaesthesia with Propofol than with Thiopentone. 
19. Lam AM., et al (2000)13 compared the onset and offset time and 
intubating condition after 1 min obtained with Rocuronium 
bromide 0.6mg/kg and Succinylcholine 1mg/kg after induction with 
Propofol and Fentanyl. They concluded that Rocuronium 0.6mg/kg, 
when used with Propofol and Fentanyl for induction, provides 
intubating conditions similar to Succinylcholine 1mg/kg at 1 minute. 
20. Cheng CAY., et al  (2002)5  compared intubating conditions of 
Succinylcholine 1.5mg/kg and Rocuronium 0.6mg/kg  and 
Rocuronium 0.9 mg/kg in children induced with Alfentanil 10μg/kg 
and Thiopentone 5-6mg/kg. Intubating conditions were excellent in 
92% with Succinylcholine 1.5mg/kg, 95% with Rocuronium 0.9 
mg/kg and 72.5% with Rocuronium 0.6mg/kg. 
 The author concluded that Rocuronium 0.9 mg/kg provides similar 
intubating conditions to Succinylcholine 1.5mg/kg at 60 seconds 
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21. Bhatia Pradeep kumar et al (2004)4 compared the intubating 
condition, onset time and duration of Succinylcholine 1.5mg/kg and 
Rocuronium 0.6mg/kg in adults patients were premedicated with 
Injection pentazocine 30mg and atropine 0.6mg/kg  30 minutes 
before  surgery. The neuromuscular blockade measured by twitch 
height in response to ulnar nerve stimulation. He concluded that the 
onset of action was 87.94 seconds and 65.89 seconds with 
Rocuronium 0.6mg/kg and Succinylcholine 1.5mg/kg respectively. 
He concluded there that is no significant difference in intubating 
condition between both groups with mean intubation score of 7.37 
and 7.79 with Rocuronium 0.6mg/kg and Succinylcholine 1.5mg/kg 
respectively. 
22. R.K.Verma .,et al (2007)19  compared the effect on intubating 
condition, onset time, clinical duration and cardiovascular effects of 
Succinylcholine 1mg/kg and Rocuronium 0.6mg/kg  and 0.9 mg/kg 
in adults elective surgical procedures after induction with 
Thiopentone 4-6mg/kg.  
The study revealed a significant difference in time between the three 
groups. Fastest with Succinylcholine 1mg/kg (52.8 ± 15) seconds, 
followed by Rocuronium 0.9mg/kg (102 ± 40) seconds and 
Rocuronium 0.6mg/kg (163 ± 58) seconds. Intubating conditions 
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were good to excellent with 92% in Succinylcholine 1.5mg/kg 
,100% in Rocuronium 0.9mg/kg and 88%in Rocuronium 
0.6mg/kg.The author concluded that Rocuronium 0.9 mg/kg 
provide similar intubating conditions to Succinylcholine 1mg/kg . 
6.  MATERIALS AND METHODS 
 This study was conducted at Government Stanley Hospital, 
Chennai, in the patients undergoing general surgical procedures. 
 After institutional approval and informed consent, 60 patients were 
enrolled in the study. 
INCLUSION CRITERIA: 
 All ASA Physical status 1 and 2 patients aged between 20-60 years 
scheduled for elective surgery under general anaesthesia. 
EXCLUSION CRITERIA 
• Modified Mallampatti Airway Classification III, IV 
• Morbidly Obese, 
• Pregnant women, 
• Neuromuscular disease, 
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• Hepatic or renal disease, 
• Patients receiving any medication known to interact with 
neuromuscular blocking agents. 
PREOPERATIVE EVALUATION 
In all the patients age, body weight, preoperative blood pressure and 
pulse rate were recorded. History regarding previous anaesthesia and 
surgery, any significant medical illness, medications and allergy were 
recorded. 
A complete physical examination and airway assessment was done. 
Laboratory investigations. 
 Hemoglobin% 
 Packed cell volume 
 Urine- Albumin, Sugar 
 Blood sugar  
 Blood Urea  
          Serum creatinine        
  
 Serum electrolytes 
          Electrocardiogram 
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          Chest X-Ray 
On arrival in the operating room intravenous access was secured 
with 18G cannula in a vein in dorsum of hand. Ringer lactate infusion 
started. Following monitors are connected. 
 Pulseoximeter 
 Electrocardiogram and  
 Non invasive blood pressure monitor 
Basal recording were noted 
PREMEDICATION 
 Inj. Midazolam 0.01mg intravenously    
          
               15 min before surgery. 
 Inj. Pentazocine 0.5mg/kg intravenously    
The patients were systematically randomized in to three groups of 
twenty each. 
Group A : Succinylcholine 1.5 mg/kg (Sch 1.5) 
Group B : Rocuronium bromide 0.6 mg/kg (2 x ED 95) 
(Roc 0.6) 
Group C : Rocuronium bromide 0.9 mg/kg (3 x ED 95) 
(Roc 0.9) 
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After preoxygenation for 3 minutes anaesthesia was induced with 
Thiopentone sodium 5mg/kg over a period of 20 seconds. 
 Respiration was assisted with 100% oxygen following loss of 
consiousness, the ulnar nerve was stimulated at the wrist using 0.1 Hz 
single twitch stimulation mode and the supramaximal current was 
determined. 
 Once a control twitch height was established the bolus of randomly 
assigned neuromuscular blocking agent was administered intravenously in 
less than 5 seconds. When injection was completed, a timer was started and 
after 20 seconds the ulnar nerve was stimulated using single twitch mode at 
a frequency of 1 Hz. 
 At one minute, intubation was performed and scored by a blinded 
experienced anaesthesiologist. 
 After intubation and observation of onset time, anaesthesia was 
maintained as appropriate for surgical needs with Nitrous oxide, oxygen 
and Neuromuscular blocking agents. 
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The following observations were recorded: 
1. Intubating Conditions: 
 Intubation conditions were scored at one minute by a scoring 
system used by Mirakhur R.K., cooper A.R. and Clarke R.S.J. (Table II and 
Table III) 
Table II 
SCORING OF INTUBATING CONDITIONS 
Score 0 1 2 3 
Jaw relaxation Poor Minimal Moderate Good 
Vocal cord 
position Closed Closing Moving Open 
Response to 
intubation 
Severe 
coughing or 
bucking 
Mild 
coughing 
Light 
diaphragmatic 
movement 
None 
 
Table III 
TOTAL SCORE 
Intubating Conditon Score 
Excellent  8-9 
Good  6-7 
Poor 3-5 
Bad 0-2 
2. Onset of action 
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 The time taken for 100% suppression of single twitch was noted. 
3. Adverse effects 
 Patients were monitored for signs of histamine release such as 
wheal, flushing, bronchospasm, tachycardia and hypotension analysis. 
 The data was computed and all values expressed as mean ± SD. The 
data was analyzed using CHI–SQUARE test, ANOVA F-test,  
P value < 0.05 is significant. 
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7.  OBSERVATION AND RESULTS 
 The study was conducted on 60 adults randomly allotted into 3 
groups as given below. 
Table IV 
DRUG AND DOSAGE SCHEDULE 
Group Drug Dosage 
Sample 
size 
Abbreviation
A Succinylcholine  1.5 mg/kg 20 Sch 1.5 
B Rocuronium  0.6 mg/kg 20 Roc 0.6 
C Rocuronium  0.9 mg/kg 20 Roc 0.9 
 
DEMOGRAPHIC PROFILE 
 Age, sex and weight are compared between three groups. 
Table V 
AGE DISTRIBUTION 
Group N Mean Age
Std. 
Deviation 
ANOVA 
F-test 
Group A(Sch 1.5) 20 38.30 11.712 
Group B (Roc 0.6) 20 35.20 9.833 
Group C (Roc 0.9) 20 36.85 11.264 
Total 60 36.78 10.854 
F=0.40 
P=0.67 
Not 
significant 
 
P Value – 0.67 – Not Significant 
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Table VI 
SEX DISTRIBUTION 
Sex 
Group 
Male Female
Total 
Group A(Sch 1.5) 8 12 20 
Group B (Roc 0.6) 11 9 20 
Group C (Roc 0.9) 10 10 20 
Total 29 31 60 
 
χ2=0.93 P=0.63 Not Significant 
Table VII 
WEIGHT DISTRIBUTION 
Group N Mean 
Std. 
Deviation 
ANOVA 
F-test 
Group A(Sch 1.5) 20 50.60 6.946 
Group B (Roc 0.6) 20 51.60 5.548 
Group C (Roc 0.9) 20 51.55 6.395 
Total 60 51.25 6.232 
F=0.16 
P=0.86 
Not significant 
 
P value – 0.86 - Not Significant 
 The age, body weight and sex distribution are not significantly 
different. 
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1. TRACHEAL INTUBATING CONDITIONS AT 1 MINUTE. 
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 The scores for jaw relaxation, vocal cord position and response to 
intubation and the total scores and compared between three groups at 1 
minute. 
Table VIII 
JAW RELAXATION 
Group Sample Size 
Jaw relaxation 
Score 3 (Good) 
Total 
Group A (Sch 1.5) 20 20 20 
Group B (Roc 0.6) 20 20 20 
Group C (Roc 0.9) 20 20 20 
 
Table IX 
VOCAL CORD POSITION 
Vocal Cords Score Group Sample 
size 
2 (Moving) 3 (Open) 
Total 
Group A (Sch 1.5) 20 3 17 20 
Group B (Roc 0.6) 20 12 8 20 
Group C (Roc 0.9) 20 1 19 20 
 
χ2=20.8 P=0.001 significant 
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 48
Table X 
RESPONSE TO INTUBATION 
Response to Intubation 
Score Group 
Sample 
size 
1 2 3 
Total
Group A(Sch 1.5) 20 0 0 20 20 
Group B (Roc 0.6) 20 11 6 3 20 
Group C (Roc 0.9) 20 0 3 17 20 
 
0 – severe cough / bucking   1 – Mild cough  
2 – light diaphragmatic movement 3 – none  
χ2=40.3 P=0.001   significant 
Table XI 
Number of patients exhibiting the different intubation score 
Total intubation score 
Excellent Good Fair Poor Group 
9 8 7 6 5 4 3 2 1 0 
Sch 1.5 18 2 0 0 0 0 0 0 0 0 
Roc 0.6 3 3 7 7 0 0 0 0 0 0 
Roc 0.9 17 2 1 0 0 0 0 0 0 0 
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Table XII 
INTUBATION SCORE 
Intubation score  Group Sample 
size 
Good Excellent  
 
Total 
Group A(Sch 1.5) 20 0 20 (100%) 20 
Group B (Roc 0.6) 20 14 (70%) 6 (30%) 20 
Group C (Roc 0.9) 20 1 (5%) 19 (95%) 20 
χ2=32.53 P=0.001 significant 
Excellent intubating conditions was seen with Group A (Sch 
1.5mg/kg) with 100% score. Excellent intubating conditions with Group B 
(Roc 0.6 mg/kg) and Group C are 30% and 85% respectively. P value of 
Succinylcholine 1.5 mg/kg and Rocuronium 0.9 mg/kg is 0.466 statistically 
not significant. 
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2.  TIME OF ONSET 
(Mean time for 100% suppression of twitch height) 
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Table XIII 
Group Sample 
size 
Mean Std. 
Deviation
Anova  
F - test  
Group A (Sch 1.5) 20 43.75 3.582 
Group B (Roc 0.6) 20 220.75 51.638 
Group C (Roc 0.9) 20 105.55 22.993 
F = 150.93 
P = 0.001 
Significant 
 
 
In group A (Sch 1.5 mg/kg) onset of action was 43.75  ± 3.582 
seconds significantly faster than either group B (Roc 0.6mg/kg) and group 
C (Roc .9mg/kg), 220.75 ± 51.638 seconds vs 105.55 ± 22.993 seconds. 
The difference in onset of action between the three groups are statistically 
significant. 
3.  EVALUATION OF ADVERSE EFFECT 
 No signs of histamine release such as wheal, flushing, 
bronchospasm, tachycardia or hypotension were not seen in any of the 
three groups 
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8.  DISCUSSION 
There has been a trend in recent years to focus on the ability of 
neuromuscular blocking agents to facilitate tracheal intubation, rather than 
the traditional measure of onset, potency and duration. 
Intubation studies are difficult to perform and interpret because 
the details of anaesthesia management, patient age, and anatomy, 
equipment and experience of the endoscopist all affect the ease of 
intubation. 
There is no accepted standardization of the background anaesthesia 
and time to laryngoscopy. The evaluation of intubating condition although 
blinded remains subjective. 
In our study, intubating conditions at one minute, onset of action 
and adverse effects were studied following administration of 
Succinylcholine 1.5mg/kg IV, Rocuronium 0.6 and 0.9 mg/kg IV in adults 
anaesthetized with Thiopentone sodium 5mg/kg IV. 
All the three groups were similar with regards to age, sex and 
weight. 
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Succinylcholine, a depolarizing muscle relaxant with its rapid onset 
and shorter duration of action is still the relaxant of choice to facilitate 
rapid tracheal intubation. Succinylcholine has got many side effects such as 
rise in serum potassium , bradycardia etc. Because most of the side effects 
of Succinylcholine is due to its depolarizing mechanism of action, search 
for ideal neuromuscular blocking agent is being focused on non 
depolarizing type of relaxants which has rapid onset and offers good to 
excellent intubating conditions.  
Rocuronium, a nondepolarizing amino steroidal muscle relaxant a 
low potency compound offers early onset of action and excellent to good 
intubating conditions. 
The dosage of Succinylcholine was selected as per text book 
description and studies done by weiss23 et al and Bhatia Pradeep 
kumar4 et al. They concluded that Succinylcholine 1.5 mg /kg IV provides 
ideal intubating conditions and quicker onset of actions. 
Studies of Bhatia pradeep kumar4 et al , Mirakhur.K17 et al and 
Cooper6 et al have shown shorter onset time and intubating conditions at 
60 seconds are excellent to good with a dose of 0.6 mg/kg IV of 
Rocuronium. 
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R.K.Verma19 et al, Cheng CAY5 et al and weiss23 et al compared 
two doses of Rocuronium at 60 seconds and concluded that 0.9 mg/kg 
provides similar intubating conditions to Succinylcholine and 0.6 mg/kg 
did not provide adequate intubating conditions  
All ASA class I and class II patients aged between 20 - 60 years 
scheduled for elective general surgical procedures under general 
anaesthesia were selected for study . 
On arrival to operating, room intravenous access secured and 
monitors connected. Injection Midazolam 0.01 mg/kg and Injection 
Pentazocin 0.5 mg/kg Intravenously given 15minutes before surgery and 
then patients were  systematically randomized in to 3 groups of 20 each  
Group A : Succinylcholine 1.5 mg/kg ( Sch 1.5 )  
Group B : Rocuronium  bromide 0.6 mg/kg( Roc 0.6 ) 
Group C : Rocuronium bromide 0.9 mg/kg ( Roc 0.9 )  
All patients were preoxygenated with 100% oxygen for 3 minutes 
and induced with Thiopentone sodium 5mg/kg, respiration was assisted 
with 100% oxygen, following loss of consciousness the ulnar nerve was 
stimulated and supramaximal current was determined  
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Once a control twitch was established the bolus of randomly 
assigned neuromuscular blocking agent was administered in less than 5 
seconds .The ulnar nerve was stimulated every 20 seconds using single 
twitch mode at frequency of 1 HZ. 
At 1 minute intubation was performed and scored by experienced 
anaesthesiologist. The following observations were recorded, Jaw 
relaxation, Vocal cords and response to intubation were recorded and 
scored by system as shown by Mirakhur R.K, Cooper A.R . and Clarke 
R.S.G et al  
The time taken for 100% suppression of single twitch was 
concluded as onset of action.  
After intubation and observation anaesthesia was maintained as 
appropriate for surgical needs with Nitrous oxide , Oxygen and 
neuromuscular blocking agent  
In our study all three groups showed good Jaw relaxation , 3 
patients in Succinylcholine 1.5 mg/kg group showed moving vocal cords 
and 12 patients in Rocuronium  0.6 mg/kg and 1 patient in Rocuronium 
0.9 mg/kg group . Regarding response to intubation 11 patients in 
Rocuronium 0.6 mg/kg group, showed mild coughing, 6 patients – light 
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diaphragmatic movement, and 3 patients showed no response . In 
Rocuronium  0.9 mg/kg  group ,3 patients showed light – light 
diaphragmatic movement, and 17 patients showed no response .In 
Succinylcholine 1.5 mg/kg group, no patient showed any response to 
intubation. 
In our study excellent intubating condition was significantly higher 
with Succinylcholine 1.5 mg/kg (100% ) compared with either dose of 
Rocuronium. Rocuronium 0.9 mg/kg (95%) had a significantly higher 
incidence of excellent intubating condition than Rocuronium 0.6 mg/kg 
(30%). There is no significant statistical difference between Rocuronium 
0.9 mg/kg and Succinylcholine 1.5 mg/kg. 
This is comparable to study of R.K.Verma19 et al , Cheng CAY5 et 
al and weiss23 et al. Mirakhur R.K17, Cooper A.R6et al showed 95 % at 
60 seconds and all patients in 90 seconds. 
In our study mean onset time were (43.75 ± 3.6) seconds with 
Succinylcholine 1.5 mg/kg and (105.6 ± 23) seconds with Rocuronium 0.9 
mg/kg and (220 ± 52) seconds with Rocuronium 0.6 mg/kg. Significant 
Statistical difference exist between all the three groups. Succinylcholine had 
a quicker onset than either dose of   Rocuronium.  
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This is similar to study of R.K.Verma 19et al showing onset time of 
52.8 seconds with Succinylcholine 1.0 mg/kg and 102.6 seconds with 
Rocuronium 0.9 mg/kg and 163 seconds Rocuronium 0.6 mg/kg  
Bhatia Pradeep kumar4 et al showed the onset of Succinylcholine 
1.5 mg/kg as 65.89 seconds and 87.94 seconds with Rocuronium 0.6 
mg/kg. Fuchs-Buder8 et al showed 193 seconds with Rocuronium 0.6 
mg/kg and 118 seconds with Rocuronium 0.9 mg/kg Wierda24 et al 
showed mean onset time of 172 seconds with Rocuronium 0.6 mg/kg . 
No evidence of histamine release was observed in any of the 
patients in the three groups in our study.  
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9. SUMMARY 
• Succinylcholine 1.5mg/kg IV gave a significantly higher incidence of 
excellent intubating conditions than either 0.6 mg or 0.9 mg/kg 
Rocuronium IV (100% vs 30% vs 85%) respectively. 
• Rocuronium 0.9 mg/kg IV produced  intubating condition similar 
to Succinylcholine  1.5mg/kg 
• Rocuronium  0.6 mg/kg IV did not produced adequate intubating 
condition 
• Succinylcholine 1.5mg/kg IV had a quicker onset (43.75 ± 3.582) 
sec than either dose of  Rocuronium0.9mg/kg (105.5±22) and 
Rocuronium 0.6mg/kg(220.75 ± 51) seconds. 
• No evidence of histamine release was observed in any of the 
patients in three groups. 
• The cost factor is high with Rocuronium Compound to 
Succinylcholine. 
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10. CONCLUSION 
• Succinylcholine is an ideal agent for intubation in all surgical 
procedures. 
• Intubating conditions of Rocuronium bromide at a dose of 
0.9mg/kg (3xED95)is comparable to Succinylcholine  1.5mg/kg at 
1minute. 
• Rocuronium bromide 0.9 mg/kg can be used safely in patients 
where Succinylcholine  is contraindicated. 
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PROFORMA 
COMPARISON OF ONSET TIME AND INTUBATING 
CONDITIONS ACHIEVED WITH SUCCINYLCHOLINE 
1.5mg/kg  IV AND ROCURONIUM 0.6mg/kg & 0.9mg/kg IV  
Name:                                                                      Study Group: 
Age:                                                                Sex: 
I.P.No.: 
Weight: 
Unit: 
PREOPERATIVE ASSESSMENT: 
Airway: 
General condition:                                                   Investigations: 
Pulse Rate:                                                               Hb: 
Blood Pressure:                                                        Urine Albumin: 
                                                                                               Sugar: 
CVS:                                                                         Blood sugar: 
RS:                                                                            Blood Urea : 
ECG:                                                                         Serum Creatinine:      
Chest X-ray:                                                              Serum Electrolytes: 
Fitness: 
PREMEDICATION 
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Injection Midazolam 0.01mg intravenously  
          15 minutes before  
Injection Pentazocine 0.5mg/kg intravenously surgery 
INDUCTION OF ANAESTHESIA: 
Preoxygenation With 100% oxygen for 3 -5 minutes 
Induction Agent Thiopentone Sodium – 5mg/kg 
Muscle Relaxant Suxamethonium – 1.5mg/kg (or) Rocuronium– 
0.6mg/kg (or) Rocuronium – 0.9mg/kg 
Mask ventilation for 60 seconds 
Intubation 
INTUBATING CONDITIONS: 
Score Jaw relaxation 
Vocal cord 
position 
Response to 
intubation 
0 Poor (Impossible) Closed Severe cough or 
bucking 
1 Minimal (Difficult) Closed Mild coughing 
2 Moderate (Fair) Moving Slight diaphragmatic 
movement 
3 Good (Easy) Open None 
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SCORE: 
Total score of intubation conditions 
        8-9 - Excellent 
        8-7 – Good 
        3-5 - Fair 
        0-2 - Poor 
TIME OF ONSET OF ACTION: 
ADVERSE EFFECTS:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 72
MASTER CHART 
GROUP A :  SUCCINYLCHOLINE  1.5mg/kg 
NAME GROUP AGE SEX
Weight 
(Kgs) 
Jaw 
relaxation
Vocal 
cords 
Response 
to 
intubation
Intubation 
score 
HANGARAJ 1 45 M 52 3 3 3 9 
ALLIGA 1 45 F 50 3 3 3 9 
NANDHI 1 20 F 42 3 2 3 9 
AUSALYA 1 57 F 40 3 3 3 9 
AMANIBAI 1 60 F 55 3 3 3 9 
UMARAVEL 1 45 M 56 3 3 3 9 
HULASI 1 29 F 45 3 2 3 8 
ANI 1 34 F 50 3 3 3 9 
ARTHASARATHY 1 30 M 60 3 3 3 9 
UMATHY 1 28 F 40 3 3 3 9 
NJALATCHI 1 50 F 42 3 3 3 9 
UDHA 1 32 F 45 3 3 3 9 
UBRAMANI 1 50 M 48 3 3 3 9 
AMALA 1 48 F 52 3 3 3 9 
UNASEKAR 1 45 M 50 3 3 3 9 
MALRAJ 1 32 M 62 3 3 3 9 
MASHANKAR  1 23 M 48 3 2 3 8 
EKAR 1 21 M 55 3 3 3 9 
ASANTHA 1 36 F 60 3 3 3 9 
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GROUP B:  ROCURONIUM 0.6mg/kg 
NAME GROUP AGE SEX 
Weight 
(Kgs) 
Jaw 
relaxation
Vocal 
cords 
Response 
to 
intubation
Intubation
score 
HANDRAN 2 26 M 52 3 2 1 6 
HUVANESHWARI 2 32 F 45 3 2 1 6 
NDARI 2 33 F 43 3 3 2 8 
TCHAI 2 43 M 50 3 2 1 6 
THI 2 25 F 50 3 2 2 7 
UVARAJ 2 32 M 56 3 2 1 6 
ARALAKSHMI 2 18 F 40 3 3 3 9 
UPPUSAMY 2 45 M 52 3 3 1 7 
NTHONI 2 35 M 60 3 2 1 6 
JESH 2 25 M 58 3 3 1 7 
RMALA 2 24 F 50 3 2 2 7 
THIMA 2 50 F 48 3 3 1 7 
ABILAN  2 32 M 58 3 2 1 7 
MANDHI 2 38 F 52 3 3 3 9 
EELAKANDAN 2 46 M 50 3 3 3 9 
ANIEL RAJ 2 26 M 53 3 3 2 8 
VAGAMI 2 50 F 55 3 2 2 7 
HERAN 2 36 M 62 3 2 1 6 
AMODARAN 2 52 M 50 3 2 2 8 
MBIKA 2 36 F 48 3 2 1 6 
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GROUP C:  ROCURONIUM 0.9mg/kg 
NAME GROUP AGE SEX 
Weight 
(Kgs) 
Jaw 
relaxation
Vocal 
cords 
Response 
to 
intubation
Intubation
score 
UTHIAH 3 50 M 55 3 3 3 9 
APAMMAL 3 46 F 50 3 3 3 9 
AMODARAN 3 55 M 58 3 3 3 9 
HUVANESHWARI 3 32 F 56 3 2 2 7 
AREEM 3 32 M 60 3 3 3 9 
TEPHEN 3 28 M 56 3 3 3 9 
RIDEVI 3 34 F 52 3 3 3 9 
UNDARI 3 33 F 43 3 3 2 8 
MRANKHAN 3 26 M 55 3 3 3 9 
UTHU 3 23 M 45 3 3 3 9 
ALARVIZHI 3 36 F 45 3 3 3 9 
INODHKUMAR 3 22 F 52 3 3 3 9 
HAMARAI 3 43 M 40 3 3 3 9 
AVEED AHMED 3 50 F 52 3 3 2 8 
OHANA 3 33 F 62 3 3 3 9 
AVANAMMAL 3 53 F 48 3 3 3 9 
ARANRAJ 3 25 M 56 3 3 3 9 
UKSHINABANU 3 21 F 42 3 3 3 9 
ANAGAVALLI 3 52 F 46 3 3 3 9 
RINIVASAN 3 43 M 58 3 3 3 9 
 
 
